BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Beta Bionics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.84+0.49 (+3.00%)
Close on Oct 19, 2026
- Market cap
- $750.14M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Beta Bionics has not reported a dividend
No dividend per share appears in Beta Bionics's annual filings since fiscal 2022.